Daily Roundup

CU6.ASX CGF.ASX VR1.ASX PXA.ASX GLH.ASX

Clarity Secures Copper-64 Manufacturing Deal, Vection Wins Defense AI Contract

Clarity Pharmaceuticals has signed a major Manufacturing Supply Agreement for copper-64 with Theragenics, a leader in radiometal production. This agreement gives Clarity access to Theragenics' 134,000 square foot facility with 14 cyclotrons near Atlanta, which can produce up to 2,000 patient doses per day. Combined with Clarity's existing copper-64 supply deals, this enhances the company's manufacturing strategy ahead of the anticipated commercial launch of its 64Cu-SAR-bisPSMA product.

In other news, Vection Technologies has secured a $1.64 million Annual Recurring Revenue (ARR) order from a classified repeat customer in the defense, intelligence, and law enforcement sector. The contract, to be fully recognized in FY26, is focused on enhancing real-time AI capabilities for Vection's multiprotocol data enrichment, retention, and correlation solutions. Vection's defense program has grown into a multi-customer, multi-domain initiative, and the company is well-positioned to capitalize on heightened geopolitical tensions driving demand for AI-powered intelligence and monitoring.

Challenger Withdraws Pepper Money Offer, Pepper Money Ends Discussions

Challenger Limited has announced that its confidential, non-binding, and conditional proposal to acquire Pepper Money is not reasonably capable of execution. Accordingly, Pepper Money has decided not to proceed with Challenger's revised proposal, and the discussions between the two companies have now ceased.

Separately, Challenger confirms that it has received all necessary regulatory approvals for its previously announced $150 million on-market share buyback.

PEXA Expands UK Footprint with NatWest Launch

PEXA Group Limited has announced the successful completion of the remortgage implementation program between its UK subsidiary, PEXA UK, and National Westminster Bank Plc (NatWest). NatWest is now transacting live on PEXA UK's platform, marking an important step in the modernization of the UK property market.

Initial digitized remortgage transactions for NatWest will use Optima Legal, a PEXA subsidiary, as the conveyancer, with the implementation program for NatWest's Sale & Purchase transactions to follow.

Global Health Delivers Stable Revenue, Improving Profitability

Global Health Limited has reported a strong H1 FY2026 performance, with 92% of its revenue now coming from recurring sources, up from 73% two years ago. The company's core business is profitable, generating an operating profit of $478K before R&D expenses, which have declined by 40.5% over the past three years.

Global Health has secured a partnership with Australia's leading practice management system provider, Best Practice, unlocking access to over 6,000 practices. The company has also integrated AI capabilities across its platforms, positioning it for productivity gains and new revenue streams.